Entering text into the input field will update the search result below

Dentsply Sirona expects Q4 sales in higher end of outlook

Jan. 11, 2023 8:55 AM ETDENTSPLY SIRONA Inc. (XRAY)By: Jonathan Block, SA News Editor

4th quarter

honglouwawa/iStock via Getty Images

  • Dentsply Sirona (NASDAQ:XRAY) said it is expecting its Q4 net sales to come in at the higher end of its previously guided range of $3.85B-$3.88B.
  • The dental equipment company also reaffirmed earlier 2022 adjusted EPS guidance of $1.90-$2.00. The consensus estimate is $1.96.
  • The consensus estimate for 2022 revenue is $3.87B.
  • Shares are up 5% in premarket trading.
  • Read why Seeking Alpha contributor Mike Zaccardi has a sell rating Dentsply Sirona (XRAY).

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About XRAY

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ConvaTec Group PLC
Bausch + Lomb Corporation
Lantheus Holdings, Inc.
Merit Medical Systems, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.